# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-158062
Filing Date
2022-05-24
Accepted
2022-05-24 08:30:36
Documents
33
Period of Report
2022-05-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d338138d8k.htm iXBRL | 8-K | 23853
2 | EX-99.1 | d338138dex991.htm | EX-99.1 | 17389
6 | GRAPHIC | g338138ex99_1p10g1.jpg | GRAPHIC | 179943
7 | GRAPHIC | g338138ex99_1p11g1.jpg | GRAPHIC | 184339
8 | GRAPHIC | g338138ex99_1p12g1.jpg | GRAPHIC | 153830
9 | GRAPHIC | g338138ex99_1p13g1.jpg | GRAPHIC | 196926
10 | GRAPHIC | g338138ex99_1p14g1.jpg | GRAPHIC | 152196
11 | GRAPHIC | g338138ex99_1p15g1.jpg | GRAPHIC | 143926
12 | GRAPHIC | g338138ex99_1p16g1.jpg | GRAPHIC | 146298
13 | GRAPHIC | g338138ex99_1p17g1.jpg | GRAPHIC | 175185
14 | GRAPHIC | g338138ex99_1p18g1.jpg | GRAPHIC | 166747
15 | GRAPHIC | g338138ex99_1p19g1.jpg | GRAPHIC | 105141
16 | GRAPHIC | g338138ex99_1p1g1.jpg | GRAPHIC | 218571
17 | GRAPHIC | g338138ex99_1p20g1.jpg | GRAPHIC | 188395
18 | GRAPHIC | g338138ex99_1p2g1.jpg | GRAPHIC | 329980
19 | GRAPHIC | g338138ex99_1p3g1.jpg | GRAPHIC | 189382
20 | GRAPHIC | g338138ex99_1p4g1.jpg | GRAPHIC | 172483
21 | GRAPHIC | g338138ex99_1p5g1.jpg | GRAPHIC | 119887
22 | GRAPHIC | g338138ex99_1p6g1.jpg | GRAPHIC | 146422
23 | GRAPHIC | g338138ex99_1p7g1.jpg | GRAPHIC | 149353
24 | GRAPHIC | g338138ex99_1p8g1.jpg | GRAPHIC | 155121
25 | GRAPHIC | g338138ex99_1p9g1.jpg | GRAPHIC | 166754
| Complete submission text file | 0001193125-22-158062.txt |  | 4907123

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | tcrt-20220524.xsd | EX-101.SCH | 2846
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tcrt-20220524_lab.xml | EX-101.LAB | 17237
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tcrt-20220524_pre.xml | EX-101.PRE | 10806
27 | EXTRACTED XBRL INSTANCE DOCUMENT | d338138d8k_htm.xml | XML | 3229

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 22954076
SIC: 2834 Pharmaceutical Preparations